Johns Hopkins Antibiotic Guide cost: ABX Guide pricing and what the bundle is worth

Infectious disease references are unusually honest about money. While the big general compendiums publish nothing at all and route every enquiry through a sales team, the two narrow antimicrobial guides most US clinicians actually choose between will both tell you exactly what they cost before you give them your name. The Johns Hopkins ABX Guide is one of them, and it is the cheaper one.

Here is the whole rate card, verified at the vendor's own pricing page in August 2026, along with the one piece of arithmetic that decides the purchase.

How much does the Johns Hopkins ABX Guide cost?

A one-year subscription is $39.95, and that single number covers the entire guide through both the mobile app and any web browser. There is no separate device tier, no web-only discount, and no cheaper mobile SKU. You either subscribe or you do not.

All figures read off the Johns Hopkins Guides pricing page in August 2026. Third-party software directories quote $29.95 and $29.99 for this product, they disagree with each other, and neither matches what the vendor publishes. Budget from the vendor page.

Is the Johns Hopkins Guides bundle worth it?

This is the only decision the pricing page actually asks you to make, and it takes ten seconds of arithmetic. The bundle is $89.95. The ABX Guide alone is $39.95. So the HIV, Diabetes and Psychiatry guides cost $50.00 for all three, about $16.67 each.

The vendor frames this as saving 44 percent, which is true if you were otherwise going to buy all four separately. Almost nobody was. The useful way to read it is the other direction: you are being offered three additional specialty references for $50, and the question is whether any one of them earns its keep.

For a general internist or a hospitalist, the diabetes guide plausibly does on its own, which makes the bundle the better buy. For an ID physician or a stewardship pharmacist who will open the ABX Guide daily and the other three never, the $50 is a donation. Buy the single guide, and revisit it at renewal rather than at signup, when you will actually know how you used it.

What the free tiers really give you

Two things here are more generous than the market norm, and one of them is genuinely useful before you spend anything.

The web preview opens roughly 10 percent of topics with no account and no card. That is not enough to practice from, and it is not meant to be, but it is enough to answer the question that actually matters before a purchase: do you like how this content is organized. Reference guides differ far more in structure than in substance, and structure is what makes a lookup fast at 2am.

The 30-day app trial is the stronger offer, mostly because of how it starts. You download the app, tap Try or Buy, and it begins. There is no form, no sales call, and no waiting on a human to approve you. That sounds like a small thing until you compare it to competitors in the same category, where trials are requested through a contact form and arrive when someone gets to them. Being able to evaluate a clinical reference on a Tuesday evening without talking to anyone is a real advantage, and it is the reason to start here even if you suspect you will end up elsewhere.

Set a calendar reminder for day 28 regardless. The trial converts to a $39.95 annual subscription rather than expiring, which is standard and fine, and is also exactly the kind of small recurring professional charge that quietly renews for years without anyone reviewing it. Clinicians who claim these against a CME or professional development allowance tend to find it easier if the receipts are captured and categorized as they arrive rather than reconstructed each January.

Johns Hopkins ABX Guide vs Sanford Guide on price

These two are the head to head, because they are the two subscription products aimed at the same job, and the price gap is not subtle.

On published price the ABX Guide wins and it is not close: half the annual cost, a self-serve trial instead of a request form, and free topics you can read today. If price were the only input, this article would end here.

It is not the only input, and the honest counterweight is familiarity. The Sanford Guide has been the format a large share of US clinicians learned antimicrobial prescribing in, and people who work fluently in it are fast in a way that does not transfer to a different information architecture. Forty dollars a year is a small price for not slowing down. That argument is completely valid for someone who already thinks in one format and completely irrelevant to someone starting fresh, which is why the trial matters more than the review. We break down the competing rate card in full in our Sanford Guide subscription cost guide, including the print editions and where the tiers stop making sense.

One point in Sanford Guide's favor on price specifically: its mobile-only tier at $34.99 is the cheapest paid entry into either product. If you genuinely only ever use a phone, that is the lowest number on this page. It also buys you less, since the ABX Guide's $39.95 includes browser access as standard.

Who publishes the Johns Hopkins ABX Guide?

The clinical content comes from Johns Hopkins Medicine. The platform, the subscription, the login and the support all run through Unbound Medicine, which also publishes Nursing Central and the Davis Drug Guide.

That split is worth knowing before you buy rather than after, because it determines who you deal with when something goes wrong. Billing questions, access problems and institutional licensing go to Unbound Medicine. It also explains the bundle structure: the four guides share a platform, which is why they can be sold together at a discount and why a single app carries all of them.

Group and institutional pricing is the one number they will not publish

The pricing page lists group discounts for schools, universities, hospitals, pharmacies, government agencies and companies, and gives you a Request Info button instead of a rate. That is the same pattern every clinical reference vendor follows, and it is worth naming plainly rather than reading as evasiveness.

Price transparency in this category tracks who signs the check. Products bought by one clinician with a personal card show a price, because a buyer who cannot see a price does not buy. Products sold into a procurement department publish nothing, because publishing a number sets a ceiling on every subsequent negotiation. The same vendor will tell an individual $39.95 and tell a hospital to get in touch.

The practical consequence for anyone negotiating: the published individual rate is your only public benchmark, and it is a useful ceiling. No volume agreement should cost more per clinician than buying one subscription at a time, and $39.95 is a specific number to bring to that conversation. The same logic applies across the category, which we work through in our guide to institutional license pricing. Before you start any of it, check whether your hospital library already licenses the guide, because a meaningful share of clinicians have access they were never told about.

Where a subscription reference stops helping

Both of these guides answer the same shape of question well: given this syndrome or this pathogen, what is reasonable therapy. That is a genuinely hard question and they are good at it.

The question neither one answers is the one sitting in front of you at the moment of signing. Does this antimicrobial interact with the other nine drugs this specific patient takes. Is it contraindicated by something in their history. Does their kidney function change the dose or the interval. Those are per-patient questions, not reference questions, and looking them up one at a time across a guide, a compendium and a calculator is how the check nobody thought to run gets skipped.

Renal function is where this bites hardest in antimicrobial prescribing, because so much of the class is renally cleared and so many labeled thresholds are still written in creatinine clearance rather than eGFR. Our breakdown of which antibiotics are safe in renal failure covers the agent-by-agent handling, and the creatinine clearance calculator runs the Cockcroft-Gault estimate on the weight basis your institution uses. The antibiotic dosing calculator checks the actual regimen rather than the class.

So which should you buy?

If you are choosing purely on published price and you have no established habit, start with the Johns Hopkins ABX Guide. It is $39.95, the trial costs nothing and starts immediately, and you can read a tenth of it before you even do that. Nothing else in this category makes it that easy to find out whether you like it.

Buy the $89.95 bundle only if you can name, now, which of the other three guides you will open. Buy Sanford Guide instead if you already work fluently in it, or if you want the print edition, which Johns Hopkins does not offer at all.

And if what you are actually short of is not a reference but a check at the point of prescribing, neither of these is the purchase. That is a different product answering a different question, and buying a third reference will not close it.